研究実績
原著
【英文】
(Suga A, Yoshitake K, Minematsu N, Tsunoda K, Fujinami K, Miyake Y, Kuniyoshi K, Hayashi T, Mizobuchi
K, Ueno S, Terasaki H, Kominami T, Nao-I N, Mawatari G, Mizota A, Shinoda K, Kondo M, Kato K, Sekiryu
T), Nakamura M, Kusuhara S, (Yamamoto H, Yamamoto S, Mochizuki K, Kondo H, Matsushita I, Kameya
S, Fukuchi T, Hatase T, Horiguchi M, Shimada Y, Tanikawa A, Yamamoto S, Miura G, Ito N, Murakami A,
Fujimaki T, Hotta Y, Tanaka K, Iwata T).
Genetic characterization of 1210 Japanese pedigrees with inherited retinal diseases by whole-exome sequencing.
Hum Mutat. 2022； Epub ahead of print:
(Sugisaki K, Inoue T, Yoshikawa K,) Kanamori A, (Yamazaki Y, Ishikawa S, Uchida K, Iwase A, Araie M)
.Factors threatening central visual function of patients with advanced glaucoma: A prospective longitudinal
observational study; Advanced glaucoma study members in Japan glaucoma society.
Ophthalmology. 2022； 129(5): 488-497
Kusuhara S, Kim KW, Miki A, Nakamura M.
Angiographic findings before and after the onset of brolucizumab-associated retinal vascular occlusion and
intraocular inflammation
Am J Ophthalmol Case Rep. 2022； 26: 101521
Kusuhara S, (Shimura M, Kitano S, Sugimoto M, Muramatsu D, Fukushima H, Takamura Y, Matsumoto M,
Kokado M, Kogo J, Sasaki M, Morizane Y, Utsumi T, Kotake O, Koto T, Terasaki H, Hirano T, Ishikawa H,
Mitamura Y, Okamoto F, Kinoshita T, Kimura K, Yamashiro K, Suzuki Y, Hikichi T, Washio N, Sato T, Ohkoshi
K, Tsujinaka H, Kondo M, Takagi H, Murata T, Sakamoto T); Japan Clinical Retina Study (J-CREST) group.
Treatment of diabetic macular edema in real-world clinical practice: The effect of aging
J Diabetes Investig 2022； 13(8): 1339-1346
(Namba K, Takase H, Usui Y, Nitta F, Maruyama K), Kusuhara S, (Takeuchi M), Azumi A, (Yanai R, Kaneko Y,
Hasegawa E, Nakai K, Tsuruga H, Morita K, Kaburaki T).
Multicenter, retrospective, observational study for the Treatment Pattern of systemic corticoSTERoids for
relapse of non-infectious uveitis accompanying Vogt-Koyanagi-Harada disease or sarcoidosis
Jpn J Ophthalmol 2022； 66(2): 130-141
Imai H, Tetsumoto A, Yamada H, Hayashida M, Otsuka K, Miki A, Nakamura M.
Intraoperative three-dimensional fluorescein angiography-guided pars plana vitrectomy for branch retinal vein
occlusion.
Retin Cases Brief Rep. 2022； 16(6): 802-805
Sakamoto M, Sawamura H, Aihara M, Goseki T, Ikeda T, Ishikawa H, Nakamura M.
Agreement in the detection of chiasmal and postchiasmal visual field defects between imo binocular random
single-eye test and Humphrey monocular test.
Jpn J Ophthalmol. 2022； 66(5): 413-424
(Kimura T, Araki T, Yasukawa T, Kato A, Kuwayama S, Kinoshita T, Okamoto F, Murakami T, Mitamura Y,
Sakamoto T, Terasaki H), Kusuhara S, Miki A, (Takamura Y, Kondo M, Matsubara H, Ueda T, Tsujinaka H,
Gomi F).Differences in clinical characteristics and treatment outcomes of submacular hemorrhage caused by
age-related macular degeneration and retinal macroaneurysms: A multicenter survey from the Japan Clinical
Retina Study (J-CREST) group.
PLoS One. 2022； 29;17(9): e0274508
(Nishi T, Ueda T, Mizusawa Y, Shinomiya K, Mitamura Y, Kimura N, Gomi F), Miki A, Nakamura (M, Kinoshita
T, Obata S, Ohji M, Tsuji T, Yoshida S, Ogata N).
Effect of foveal morphology on visual acuity in 4-6-year-old children with retinopathy of prematurity: a
a -CREST study.
Sci Rep. 2022； 30;12(1): 16431
(Sugisawa T, Ishikawa H, Uchida K, Takesue Y, Mori J, Kinoshita T, Morikawa S, Okamoto F, Sawada T, Ohji
M, Kanda T, Takeuchi M), Miki A, Kusuhara S, (Ueda T, Ogata N, Sugimoto M, Kondo M, Yoshida S, Ogata T,
Kimura K, Mitamura Y, Jujo T, Takagi H, Terasaki H, Sakamoto T, Komuku Y, Gomi F).
Risk factors for legal blindness in 77 Japanese patients with endogenous endophthalmitis: A multicenter cohort
study from J-CREST.
Ocul Immunol Inflamm. 2022； 25: 1-8
(Inoue N, Kato A, Araki T, Kimura T, Kinoshita T, Okamoto F, Murakami T, Mitamura Y, Sakamoto T), Miki A,
(Takamura Y, Matsubara H, Tsujinaka H, Gomi F, Yasukawa T).
Visual prognosis of submacular hemorrhage secondary to age-related macular degeneration: A retrospective
multicenter survey.
PLoS One. 2022； 21;17(7): e0271447
(Zhou X, Komuku Y, Araki T, Hozumi K, Terasaki H), Miki A, (Kuwayama S, Niki M, Matsubara H, Kinoshita T,
Nishi T, Gomi F).
A multicentre study of the risk factors associated with recurrence of central serous chorioretinopathy.
Acta Ophthalmol. 2022； Epub ahead of print:
(Zhou X, Komuku Y, Araki T, Terasaki H), Miki A, (Kuwayama S, Nishi T, Kinoshita T, Gomi F).
Risk factors and characteristics of central serous chorioretinopathy with later development of macular
neovascularisation detected on OCT angiography: a retrospective multicentre observational study.
BMJ Open Ophthalmol. 2022； 7(1): e000976
(Mori Y, Miyake M, Hosoda Y), Miki A, (Takahashi A, Muraoka Y, Miyata M, Sato T, Tamura H, Ooto S,
Yamada R, Yamashiro K), Nakamura M, (Tajima A, Nagasaki M, Honda S, Tsujikawa A).
Genome-wide survival analysis for macular neovascularization development in central serous chorioretinopathy
revealed shared genetic susceptibility with polypoidal choroidal vasculopathy.
Ophthalmology. 2022； 129(9): 1034-1042
(Shijo T, Sakurada Y, Tanaka K), Miki A, (Sugiyama A, Onoe H), Chubachi A, (Kikushima W, Wakatsuki Y,
Yoneyama S, Mori R, Kashiwagi K).
Incidence and risk of advanced age-related macular degeneration in eyes with drusenoid pigment epithelial
detachment.
Sci Rep. 2022； 18;12(1): 4715
(Akiyama M, Miyake M, Momozawa Y, Arakawa S, Maruyama-Inoue M, Endo M, Iwasaki Y, Ishigaki K,
Matoba N, Okada Y, Yasuda M, Oshima Y, Yoshida S, Nakao SY, Morino K, Mori Y, Kido A, Kato A, Yasukawa T,
Obata R, Nagai Y, Takahashi K, Fujisawa K), Miki A, Nakamura M, (Honda S, Ushida H, Yasuma T, Nishiguchi
KM, Mori R, Tanaka K, Wakatsuki Y, Yamashiro K, Kadonosono K, Terao C, Ishibashi T, Tsujikawa A, Sonoda KH,
Kubo M, Kamatani Y).
GWAS of age-related macular degeneration reveals two new loci implying shared genetic components with
central serous chorioretinopathy.
Ophthalmology. 2022； S0161-6420(22)00900-9.
(Ghoraba HH), Matsumiya W, (Khojasteh H, Akhavanrezayat A, Karaca I, Or C, Yavari N, Lajevardi S, Hwang J,
Yasar C, Do D, Nguyen QD).
Safety of intravenous methylprednisolone in refractory and severe pediatric uveitis.
Clin Ophthalmol. 2022； 16: 1697-1706
(Ghoraba HH, Akhavanrezayat A, Karaca I, Yavari N, Lajevardi S, Hwang J, Regenold J), Matsumiya W, (Pham
B, Zaidi M, Mobasserian A, DongChau AT, Or C, Yasar C, Mishra K, Do D, Nguyen QD).
Ocular gene therapy: A literature review with special focus on immune and inflammatory responses.
Clin Ophthalmol. 2022； 16: 1753-1771
(Zaidi M, Mishra K, Nguyen HV, Miller PP, Ghoraba H, Karaca I), Matsumiya W, (Nguyen QD, Leung LB).
C3 glomerulopathy associated with both hypertensive retinopathy and purtscher-like retinopathy.
Am J Ophthalmol Case Rep. 2022； 27: 1-7
(Ghoraba HH), Matsumiya W, (Or C, Khojasteh H, Patel P, Karaca I, Regenold J, Zaidi M, Hwang J, Lajevardi S,
Yavari N, Than NTT, Park SW, Akhavanrezayat A, Uludag G, Yasar C, Leung LB, Nguyen QD).
Electroretinographic findings in retinal vasculitis.
Br J Ophthalmol. 2022； Epub ahead of print.:
(Uludag G, Hassan M), Matsumiya W, (Pham BH, Chea S, Trong Tuong Than N, Doan HL, Akhavanrezayat A,
Halim MS, Do DV, Nguyen QD).
Efficacy and safety of intravitreal anti-VEGF therapy in diabetic retinopathy: what we have learned and what
should we learn further?
Expert Opin Biol Ther. 2022； 10: 1275-1291
(Mobasserian A, Zaidi M, Halim S, Hwang JJ, Regenold J, Akhavanrezayat A, Karaca I, Khojasteh Jafari H,
Yavari N), Matsumiya W, (Yasar C, Than NTT, Uludag G, Do D, Ghoraba H, Nguyen QD).
Effect of Pupil Size on Fixed-Luminance Flicker Full-Field Electroretinogram Magnitude.
Clin Ophthalmol. 2022； 16: 3733-3740
(Karaca I, Uludag G), Matsumiya W, (Regenold J, Or C, Mobasserian A, Halim MS, Zaidi M, Lajevardi S,
Dongchau A, Ghoraba H, Nguyen QD).
Six-month outcomes of infliximab and tocilizumab therapy in non-infectious retinal vasculitis.
Eye (Lond). 2022； Epub ahead of print.:
(Uludag G, Karaca I, Akhavanrezayat A, Yasar C), Matsumiya W, (Pham BH, Halim MS, Trong Tuong Than N,
Sepah YJ, Do DV, Nguyen QD).
Efficacy and safety of tocilizumab in the management of non-infectious uveitis failed with conventiona
immunomodulatory and anti-TNF α therapies.
Ocul Immunol Inflamm. 2022； Epub ahead of print.:
(Yoneda Y, Usui Y, Tanaka R, Hase K, Namba K, Kamoi K, Takase H, Takeuchi M), Matsumiya W, Kusuhara S,
(Takeda A, Yawata N, Yanai R, Hiyama T, Harada Y, Hashida N, Maruyama K, Nakai K, Taguchi R, Kaburaki T,
Changesingeneexpressionprofilingandphenotypeinagedmultidrugresistanceprotein
Mizuki N, Goto H, Fujino Y, Takeuchi M).
Factors associated with low prevalence of Fuchs' uveitis syndrome in Japan
Front Med (Lausanne) 2022； 9: 999804
Yasuda E, Matsumiya W, Maeda Y, Kusuhara S, Nguyen QD, Nakamura M, Hara R.
Multiple evanescent white dot syndrome following BNT162b2 mRNA COVID-19 vaccination.
Am J Ophthalmol Case Rep. 2022； 26: 101532
Mori S, (Tanito M, Shoji N, Yokoyama Y, Kameda T, Shoji T, Mizoue S, Saito Y, Ishida K, Ueda T), Nakamura M;
TramTrac Study Group, Namiguchi K, Mizoue S, Ishida K, Inoue K, Kono Y, Kasahara M, Shoji N), Matsumiya W,
Mori S, Nagai T, Nakamura M, (Kameda T, Akagi T, Ueda T, Makita J, Shoji T, Kono M, Tanito M, Yokoyama K,
Saito Y, Ishida K, Yokoyama Y, Nakazawa T).
Noninferiority of microhook to Trabectome: Trabectome versus ab interno microhook trabeculotomy
comparative study (Tram Trac Study).
Ophthalmol Glaucoma. 2022； 5(4): 452-461
Sotani N, Kusuhara S, Matsumiya W, Okuda M, Mori S, Sotani R, Kim KW, Nishisho R, Nakamura M.
Outcomes of microhook ab interno trabeculotomy in consecutive 36 eyes with uveitic glaucoma.
J Clin Med. 2022； 11(13): 3768
Takano F, Mori S, Okuda M, Murai Y, Ueda K, Sakamoto M, Kurimoto T, Yamada-Nakanishi Y, Nakamura M.
Risk of surgical failure and hemorrhagic complications associated with antithrombotic medication in glaucoma
surgery.
Graefes Arch Clin Exp Ophthalmol. 2022； 260(11): 3607-3615
Takano F, Ueda K, (Godefrooij DA, Yamagami A, Ishikawa H, Chuman H, Ishikawa H, Ikeda Y, Sakamoto T),
Nakamura M.
Incidence of leber hereditary optic neuropathy in 2019 in Japan: a second nationwide questionnaire survey.
Orphanet J Rare Dis. 2022； 17(1): 319
Okuda M, Mori S, Takano F, Murai Y, Ueda K, Sakamoto M, Kurimoto T, Yamada-Nakanishi Y, Nakamura M.
Association of the prolonged use of anti-glaucoma medications with the surgical failure of ab interno microhook
trabeculotomy.
Acta Ophthalmol. 2022； 100(6): e1209-e1215
Sakai D, (Takagi S, Totani K, Yamamoto M, Matsuzaki M, Yamanari M, Sugiyama S, Yokota S, Maeda A,
Hirami Y, Mandai M, Takahashi M), Nakamura M, (Kurimoto Y).
Retinal pigment epithelium melanin imaging using polarization-sensitive optical coherence tomography for
patients with retinitis pigmentosa.
Sci Rep. 2022； 12(1): 7115
Sakai D, (Demoto S, Iwai Y, Hirami Y), Nakamura M, (Kurimoto Y).
Comparison of the accuracy of intraoperative aberrometry in intraocular lens implantation between myopic
eyes with emmetropia and myopia targets.
Clin Ophthalmol. 2022； 16: 1165-1171
Sakai D, (Yokota S, Maeda A, Hirami Y), Nakamura M, (Kurimoto Y).
Ocular biometry with swept-source optical coherence tomography-based optical biometer in Japanese patients
with EYS-related retinitis pigmentosa: a retrospective study.
BMC Ophthalmol. 2022； 22(1): 51
Sakai D, (Takagi S, Hirami Y), Nakamura M, (Kurimoto Y).
Use of ellipsoid zone width for predicting visual prognosis after cataract surgery in patients with retinitis
pigmentosa.
Eye (Lond). 2022； Epub ahead of print: 34974539
Sakai D, (Hirami Y, Sugita S, Maeda A), Matsumiya W, Nakamura M, (Kurimoto Y).
A case of rapidly progressive retinopathy associated with pembrolizumab immunotherapy for metastatic
urothelial carcinoma.
Retinal Cases & Brief Reports. 2022； Online ahead of print:
Sakai D, (Takagi S, Totani K), et al.
Retinal pigment epithelium melanin imaging using polarization-sensitive optical coherence tomography for
patients with retinitis pigmentosa.
Sci Rep. 2022； 12(1): 7115
Sakai D, (Tomita H, Maeda A).
Optogenetic Therapy for Visual Restoration.
Int J Mol Sci. 2022； 23: 15041
Sakai D, (Yamamoto S, Yoshimizu S, Hirose F, Fujihara M), Nakamura M, (Kurimoto Y).
Ten-year outcomes of cataract surgery for glaucoma management in patients with primary angle-closure
disease.
Jpn J Ophthalmol. 2022； Online ahead of print:
Sotani Y, Imai H, Iwane Y, Yokogawa T, Yamada H, Matsumiya W, Miki A, Kusuhara S, Nakamura M.
Intraoperative optical coherence tomography for real-time visualization of the positional relationship between
buckling material and retinal breaks during scleral buckling for rhegmatogenous retinal detachment.
Retina. 2022； 42(12): 2395-2400
Iwane Y, Imai H, Yamada H, Sotani Y, Oishi M, Nakamura M.
Removal of subfoveal massive hard exudates through an intentional macular hole in patients with diabetic
maculopathy: A report of three cases.
Case Rep Ophthalmol. 2022； 13(2): 649-656
(Takeuchi M, Nakai S, Usui Y, Namba K, Suzuki K, Harada Y), Kusuhara S, (Kaburaki T, Tanaka R, Takeuchi M,
Mizuki N, Nakai K, Goto H, Herbort CP Jr).
Adalimumab treatment for chronic recurrent Vogt-Koyanagi-Harada disease with sunset glow fundus: A
multicenter study
Saudi J Ophthalmol 2022； 36(4): 380-386
(Komori R, Takamura Y, Yamada Y, Morioka M, Matsubara H, Hirano T, Mitamura Y, Shimizu M), Kusuhara S,
(Murakami T, Nihei R, Ueda T, Kunikata H, Jujo T, Terasaki H, Nagasato D, Noda K, Osaka R, Nagai K
Yoshida S, Nozaki M, Noma H, Ishigooka G, Takahashi A, Sawada O, Kimura K, Inatani M).
Impact of the COVID-19 Pandemic on Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular
Edema in Japan
J Clin Med 2022； 11(22): 6794
【和文】
江本 美佐、坂本 麻里、曽谷 尭之、高野 史生、村井 祐輔、西庄 龍東、盛 崇太朗、大塚 尚美、高木 泰孝
堀 清貴、中村 誠
緑内障患者に対する点眼補助具（Just in）の使用感アンケート調査
あたらしい眼科 39（6）：808-813，2022
高野 史生、上田 香織、中西 裕子、鎌田 誠子、中村 誠
当院における皮膚電極 ERG HE-2000 の使用経験
眼科臨床紀要 15（5）：353-357，2022
酒井 大輝、（前田 忠郎、高橋 政代）
加齢黄斑変性治療における iPS 細胞移植実用化への課題 Prog. Med.42：1045~1049，2022
延吉 章、木村 将、越猪 早織、川村 知子、田邊 益美、（橋本 大）
緑内障点眼アレルギー症状が涙嚢鼻腔吻合術後に改善し点眼再開が可能となった 1 例臨床眼科 76（5）：643-647，
2022
中野由美子、野村 耕治
当院における先天性外眼筋線維症４例の手術成績臨床眼科 76（10）：1422-1426，2022